- Home
- Life Sciences
- Pharmaceutical
- Drug Discovery and Development
- Drug Discovery and Development Analysis & Statistics in France, May 2013
Talk to Alison
00 1 718 618 48 97
Search inside this page
Publication dates
Publishers
data types
Free Market Research Guides to Download
Drug Discovery and Development Analysis & Statistics in France, May 2013
You might be interested in: clinical trial, drug discovery, drug development, more »
» Purchase Premium Reports
1-25 of 20 reports
Teknimed S.A. - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- May 2013
- by Global Data
Summary Teknimed S.A. (Teknimed) is a medical device company. The company develops and manufactures orthopedic products. Its products include acrylic bone cements, resorbable obturators, bone substitutes, ...
- Industries : Drug Discovery and Development
- Countries : France
Spineway (ALSPW) - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- April 2013
- by Global Data
Summary Spineway is a medical device company. It specializes in design, development, manufacture and supply of implants for spinal column surgery. The company's products include posterior fusion system, ...
- Industries : Drug Discovery and Development
- Countries : France, Venezuela, Spain, China
France Phase Iii Clinical Trials
- $ 250
- Industry data
- January 2013
Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.
- Industries : Drug Discovery and Development
- Countries : France
France Phase Iv Clinical Trials
- $ 250
- Industry data
- January 2013
Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.
- Industries : Drug Discovery and Development
- Countries : France
France Total Clinical Trials
- $ 250
- Industry data
- January 2013
Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.
- Industries : Drug Discovery and Development
- Countries : France
France Phase I Clinical Trials
- $ 250
- Industry data
- January 2013
Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.
- Industries : Drug Discovery and Development
- Countries : France
France Phase Ii Clinical Trials
- $ 250
- Industry data
- January 2013
Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.
- Industries : Drug Discovery and Development
- Countries : France
Drug Discovery and Development Industry: Innate Pharma SA - Product Pipeline Review - Q4 2010
- $ 1 500
- Company report
- December 2012
- by Global Markets Direct
The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...
- Industries : Drug Discovery and Development
- Countries : France
Vexim SAS - Product Pipeline Analysis
- $ 750
- Company report
- November 2012
- by Global Data
Summary Vexim SAS (Vexim) is a healthcare products manufacturer, based in France. It provides development and manufacturing of clinically and scientifically proven minimally invasive solutions for treatment ...
- Industries : Drug Discovery and Development
- Countries : France, Germany, Europe
Medixsysteme - Product Pipeline Analysis
- $ 750
- Company report
- November 2012
- by Global Data
Summary Medixsysteme is a therapeutic medical device company, which is engaged in the development, manufacture and sales of medical equipments related to medical aesthetic. The company offers products, ...
- Industries : Drug Discovery and Development
- Countries : France, World
Celsis International Ltd. SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
Celsis International Ltd. (Celsis) provides innovative life science products and laboratory services to pharmaceutical, biopharmaceutical, and consumer products industries. The company operates through ...
- Industries : Drug Discovery and Development
- Countries : United States, Netherlands, United Kingdom, France, Germany, Belgium
Cerep SA (ALCER) - Financial and Strategic SWOT Analysis Review
- $ 125
- Company report
- November 2012
- by Global Data
Summary Cerep SA (Cerep) focuses on offering in vitro and in vivo solutions. The solutions allow early discovery of encouraging drug candidates and terminating compounds likely to fail in development. ...
- Industries : Drug Discovery and Development
- Countries : Canada, France, Australia
Next-Generation Superfruits
- $ 2 875
- Industry report
- September 2012
- by Datamonitor
This report examines the emerging market of superfruits within the global food and drinks market, analyzing data from four metrics: product launches, patent applications, health claim applications, and ...
- Industries : Drug Discovery and Development
- Countries : Russian Federation, France, Germany
Groupe Forenap SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- August 2012
- by Global Data
Groupe Forenap is a contract research organization (CRO). The Group includes two businesses, namely, Forenap Pharma (Forenap) and Forenap R&D. Forenap is an international CRO engaged in providing a wide ...
- Industries : Drug Discovery and Development
- Countries : France
OLEA Medical - Product Pipeline Analysis
- $ 750
- Company report
- August 2012
- by Global Data
OLEA Medical - Product Pipeline Analysis Summary OLEA Medical (Olea Medical) is a pharmaceutical and healthcare company, based in France. It designs and markets innovative medical imaging software. The ...
- Industries : Drug Discovery and Development
- Countries : France, Canada
Drug Discovery and Development: MEDICREA INTERNATIONAL (ALMED)
- $ 750
- Company report
- August 2012
- by Global Data
This report is a source for data, analysis and actionable intelligence on the MEDICREA INTERNATIONAL portfolio of new product development . The report provides detailed analysis on each pipeline product ...
- Industries : Drug Discovery and Development
- Countries : France
Drug Discovery and Development: IRAMED GmbH
- $ 750
- Company report
- June 2012
- by Global Data
This report is a source for data, analysis and actionable intelligence on the IRAMED GmbH portfolio of new product development . The report provides detailed analysis on each pipeline product with data ...
- Industries : Drug Discovery and Development
- Countries : Germany, France
In Vitro Diagnostic: TcLand Expression
- $ 750
- Company report
- June 2012
- by Global Data
This report is a source for data, analysis and actionable intelligence on the TcLand Expression portfolio of new product development . The report provides detailed analysis on each pipeline product with ...
- Industries : Drug Discovery and Development
- Countries : France
Respiratory Syncytial Virus (RSV) Prophylactic - Pipeline Assessment and Market Forecasts to 2019
- $ 3 995
- Company report
- January 2012
- by Global Data
Respiratory Syncytial Virus (RSV) Prophylactic - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, ?Respiratory Syncytial ...
- Industries : Drug Discovery and Development
- Countries : World, Japan, Spain, Italy, France, Germany, United States, Europe, United Kingdom
Global Clinical Trial Market (2007 - 2010) (Key Therapeutic Categories, Country Wise Metrics & Regulatory Approval Framework)
- $ 4 650
- Industry report
- September 2011
- by MarketsandMarkets
Report Description: Clinical trials market now witness a paradigm shift. Naïve heterogeneous patient populations in the developing nations is opening up new avenues for the clinical trials market. Developing ...
- Industries : Drug Discovery and Development
- Countries : World, South Korea, Argentina, Europe, Brazil, Mexico, Canada, Ukraine, Spain, Russian Federation, Poland, Italy, France, Germany, India, China, South America, Asia, United Kingdom, North America
Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies
- $ 3 500
- Industry report
- March 2011
- by GBI Research
Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies Summary GBI Research, the leading business intelligence provider, has released its ...
- Industries : Drug Discovery and Development
- Countries : World, United States, Europe, Switzerland, Sweden, Spain, Italy, France, Germany, Denmark, Belgium, Canada
Pathology in France: French National Agency for Research on AIDS and Viral Hepatitis - Developmental Therapeutics Review - Q4 2010
- $ 500
- Company report
- November 2010
- by Global Markets Direct
The report includes data on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable). It also gives a complete picture of the institute's future ...
- Industries : Pathology, Drug Discovery and Development
- Countries : France
Expert Opinion : Osteoarthritis - Drug development lags behind rising osteoarthritis population
- $ 15 200
- Industry report
- December 2009
- by Datamonitor
About This Report Datamonitor expect osteoarthritis prevalence to grow by over 10 million by 2020, owing mainly to an aging population. In the near-term the approach to treatment will remain constant, ...
- Industries : Pathology, Drug Discovery and Development
- Countries : Japan, United States, Spain, Italy, France, Germany, Europe
LDR Holding Corporation Product Development Pipeline
- $ 750
- Industry report
- January 2009
- by Global Markets Direct
The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development. Scope of ...
- Industries : Drug Discovery and Development, Medical Devices
- Countries : United States, France
Currently Druggable in Breast Cancer: A Drug Target Competitive Analysis
- $ 2 925
- Industry report
- August 2008
- by Bioseeker
This report aims to analyze the current and future potential of breast cancer pipeline by examining key fundamentals across the entire pipeline of drug candidates. The author has identified three fundamental ...
- Industries : Drug Discovery and Development, Biotechnology
- Countries : South Korea, Europe, New Zealand, Australia, United Kingdom, Switzerland, Netherlands, World, Canada, Sweden, Norway, Italy, Ireland, France, Germany, Finland, Denmark, Austria, Japan, Israel, India, China
» Download Public Reports
25 reports
Company Report: Clinical Trial in France and The United States for Year 2011
- Company report
- June 2011
- 10 pages
... Compared with 18.6 Million euros in the six-month period ended june 30, 2010. This increase was due principally to the increase in expenses relating to clinical trials as well as to increased r ...
Ipsen S.a. - Annual Report 2011
March 2011Reportlinker.com © Copyright 2013. All rights reserved.
